MOTS-c is a mitochondrial-derived peptide regulating metabolic homeostasis, while NAD+ is a fundamental pyridine nucleotide coenzyme mediating cellular redox reactions and enzyme activation. For high-purity experimental reagents, PX1 Research supplies USA-synthesized MOTS-c and NAD+ backed by lot-specific third-party HPLC/MS and endotoxin testing, verified above 99% purity, with same-day dispatch M–F from California and Arizona.
MOTS-c is a mitochondrial-derived peptide regulating metabolic homeostasis, while NAD+ is a fundamental pyridine nucleotide coenzyme mediating cellular redox reactions and enzyme activation. For high-purity experimental reagents, PX1 Research supplies USA-synthesized MOTS-c and NAD+ backed by lot-specific third-party HPLC/MS and endotoxin testing, verified above 99% purity, with same-day dispatch M–F from California and Arizona.
While both compounds are integral to cellular bioenergetics and mitochondrial research, MOTS-c and NAD+ belong to distinct biochemical classes and act through separate molecular pathways. MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino-acid peptide encoded within the mitochondrial genome that translocates to the nucleus under metabolic stress to regulate gene expression.
In contrast, Nicotinamide Adenine Dinucleotide (NAD+) is an essential coenzyme found in every living cell, functioning as a primary electron acceptor in glycolysis and oxidative phosphorylation while serving as a substrate for sirtuins and PARP enzymes.
Researchers evaluating these reagents often study MOTS-c for its downstream signaling influence on AMPK activation, glucose transporter translocation, and systemic metabolic flexibility in animal models. Investigators utilize NAD+ to measure direct redox coupling, mitochondrial respiration, cellular senescence markers, and enzymatic longevity pathways in cellular and rodent models.
Both reagents require precise handling, lot-specific verification, and reliable analytical purity to yield reproducible experimental data. Laboratories can source verified batches directly through PX1 Research.
MOTS-c is a naturally occurring peptide encoded by a short open reading frame (sORF) within the mitochondrial 12S ribosomal RNA gene. Discovered during investigations into mitochondrial-derived signaling molecules, MOTS-c consists of a specific 16-amino-acid sequence (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg). It represents a novel class of mitochondrial signals termed mitochondrial-derived peptides (MDPs).
In cell cultures and animal models, MOTS-c behaves as a metabolic hormone. Under basal conditions, it targets skeletal muscle tissue to preserve metabolic homeostasis. Under cellular or physical stress, MOTS-c translocates to the nucleus, where it binds to specific promoter regions alongside transcription factors such as NRF2 to regulate adaptative nuclear gene expression.
Key areas of investigation for MOTS-c include AMPK pathway activation, insulin sensitivity mechanisms, fat oxidation, and physical performance optimization in aged animal models. Researchers interested in exploring these pathways can review detailed technical data in our MOTS-c research guide or proceed to buy MOTS-c vials for laboratory research.
Nicotinamide Adenine Dinucleotide (NAD+) is a dinucleotide coenzyme composed of two nucleotides joined through their phosphate groups, one containing an adenine nucleobase and the other nicotinamide. Unlike peptides, which are chains of amino acids synthesized via ribosomal or non-ribosomal peptide bonds, NAD+ is a non-protein organic cofactor essential for metabolic catalysis.
NAD+ exists in two forms within biological systems: the oxidized form (NAD+) and the reduced form (NADH). The ratio of NAD+ to NADH directly dictates cellular redox state, driving ATP production in the electron transport chain during cellular respiration. Beyond energy transfer, NAD+ acts as a required co-substrate for key regulatory enzymes, including sirtuins (SIRT1–SIRT7), poly(ADP-ribose) polymerases (PARPs), and cyclic ADP-ribose synthases (CD38/CD157).
Because intracellular NAD+ levels decline marked by tissue aging and metabolic strain in animal models, NAD+ replenishment models are widely utilized in preclinical research targeting cellular repair, mitochondrial biogenesis, and epigenetic maintenance. For detailed mechanistic literature, examine our NAD+ background paper or order analytical-grade NAD+ vials.
The primary difference between MOTS-c and NAD+ lies in their biochemical classification and cellular operational levels. MOTS-c acts as an upstream signaling peptide, initiating enzymatic cascades and nuclear transcription programs. NAD+ operates as a direct chemical mediator of enzymatic reactions and mitochondrial electron transport.
When MOTS-c activates the 5'-AMP-activated protein kinase (AMPK) pathway in experimental models, it increases intracellular levels of NAD+ indirectly by stimulating NAMPT (nicotinamide phosphoribosyltransferase), the rate-limiting enzyme in the NAD+ salvage pathway. Thus, MOTS-c signaling can lead to elevated endogenous NAD+ synthesis in targeted cells.
Conversely, providing exogenous NAD+ directly restores the cellular pool of coenzymes required for immediate substrate oxidation and sirtuin activity without requiring nuclear signaling transcription steps. Researchers comparing signaling activation speed often utilize MOTS-c for gene expression and systemic metabolic remodeling models, whereas NAD+ is preferred for direct enzymatic kinetic assays and acute bioenergetic stress models.
To assist research laboratories in selecting the correct analytical reagent for their specific experimental design, the following detailed criteria outline the physical, structural, and functional distinctions between MOTS-c and NAD+:
• Biochemical Class: MOTS-c is a 16-amino-acid mitochondrial-derived peptide; NAD+ is a pyridine dinucleotide coenzyme.
• Primary Receptor Target/Mechanism: MOTS-c targets AMPK/NRF2 nuclear translocation pathways; NAD+ functions as an electron carrier in redox reactions and substrate for SIRT/PARP enzymes.
• Preclinical Evidence Base: MOTS-c is investigated for metabolic regulation, insulin sensitivity, and exercise capacity in aging models; NAD+ is investigated for cellular longevity, DNA repair, mitochondrial bioenergetics, and redox balance.
• Available Vial Formulations: MOTS-c is supplied as lyophilized powder in 10 mg vials; NAD+ is supplied as lyophilized powder in 100 mg and 500 mg research vials.
• Handling and Stability: MOTS-c requires reconstituting in sterile or bacteriostatic water, stable at -20°C; NAD+ is highly hygroscopic, sensitive to light and moisture, requiring careful buffer preparation and immediate freezing at -20°C or -80°C.
• Typical Laboratory Protocol Use: MOTS-c is utilized in cell culture models, gene expression profiling, and rodent metabolic studies; NAD+ is utilized in enzyme activity assays, isolated mitochondrial respiration assays, and systemic cellular strain assays.
Given their complementary roles in cellular metabolism, combined experimental protocols involving both MOTS-c and NAD+ have gained traction in mitochondrial bioenergetics research. Because MOTS-c stimulates upstream gene transcription and AMPK activation, and NAD+ powers downstream sirtuin deacetylation and electron transport, co-administration protocols allow researchers to evaluate potential synergistic effects on mitochondrial density and ATP turnover.
In preclinical metabolic disease models, dual-arm studies measure whether priming signaling cascades with MOTS-c enhances the biological clearance and utilization of replenished NAD+ pools. Investigators conducting dual-pathway protocols frequently incorporate additional mitochondrial compounds such as SS-31 to stabilize mitochondrial inner membrane cardiolipin during oxidation.
When designing multi-compound protocols, laboratories must establish isolated single-variable controls alongside combined arms to accurately differentiate gene regulatory effects from direct coenzyme redox kinetics. Review our complete catalog of mitochondrial research peptides for complementary reagents.
Proper reconstitution and storage procedures are essential to maintain the integrity and bioactivity of both MOTS-c and NAD+. Lyophilized peptides and coenzymes are susceptible to degradation if exposed to heat, moisture, or repeated freeze-thaw cycles.
For MOTS-c, bring the vial to room temperature before reconstitution to prevent condensation inside the container. Reconstitute using sterile laboratory-grade solvent or bacteriostatic water by allowing the liquid to run gently down the inner glass wall. Avoid aggressive agitation or vortexing; invert the vial gently until completely dissolved. Store reconstituted aliquots at -20°C for up to 90 days, or -80°C for extended storage.
NAD+ is extremely hygroscopic and sensitive to hydrolytic cleavage in aqueous solution. Reconstitution should be performed immediately prior to use using cold, neutral-pH sterile buffers or laboratory water. Avoid prolonged storage of dissolved NAD+ at room temperature. Aliquot reconstituted stock solutions immediately into single-use microcentrifuge tubes and freeze rapidly at -80°C to minimize degradation into nicotinamide and ADP-ribose.
Sourcing high-purity research compounds requires rigorous verification to ensure experimental accuracy and reproducibility. Substandard reagents containing residual solvents, TFA salts, synthesis side-products, or bacterial endotoxins can invalidate cell viability studies and animal trial data.
When evaluating vendors for MOTS-c, NAD+, or related agents like SS-31 peptides, watch for these critical red flags:
1. Missing Lot-Specific COAs: Reputable vendors provide accessible, full-spectrum HPLC and Mass Spectrometry reports for every batch, rather than generic static certificates.
2. Absence of Endotoxin Testing: Research reagents used in animal or sensitive cell models must undergo Chromogenic LAL testing to verify low endotoxin levels (<0.01 EU/mg).
3. Imprecise Purity Statements: Vendor claims of 'high purity' without quantitative HPLC peak integration percentages indicating ≥99% purity indicate poor quality control.
4. Consumer Dosing or Medical Marketing: Legitimate research suppliers never present dosing calculators, therapeutic claims, or human consumption instructions. Products sold for laboratory research must adhere strictly to in vitro and preclinical research framing.
5. Opaque Sourcing: Suppliers that fail to disclose US-based synthesis quality checks, analytical testing parameters, or domestic dispatch facilities pose high risk for batch inconsistency.
PX1 Research is the premier vendor for analytical-grade research peptides and bioenergetic compounds across the United States. We serve academic institutions, private biotechnology laboratories, and contract research organizations requiring uncompromising reagent consistency.
Every lot of MOTS-c 10 mg vials and NAD+ research vials undergoes rigorous third-party testing in independent US laboratories. Each batch is verified for exact molecular mass via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS), alongside quantitative endotoxin verification. Certificate of Analysis (COA) documents are published directly for immediate researcher download.
Orders placed before 1:00 PM EST Monday through Friday ship same-day from our secure distribution centers in California and Arizona. Packages are shipped via expedited domestic carriers with full tracking details to ensure cold-chain stability during transit. Our technical support team is staffed by knowledgeable research specialists ready to assist with lot verification, COA requests, and order inquiries. Order MOTS-c and NAD+ reagents today to support your lab's experimental timeline.
What is the key difference between MOTS-c and NAD+?
MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA that acts as a signaling molecule to activate nuclear transcription and AMPK pathways. NAD+ is a pyridine nucleotide coenzyme essential for direct electron transfer in redox reactions and serves as a direct substrate for sirtuin and PARP enzymes.
Are MOTS-c and NAD+ legal to purchase for research in the US?
Yes. MOTS-c and NAD+ are fully legal to purchase across the United States as research chemicals intended strictly for laboratory, in vitro, and preclinical research applications. They are not approved for human consumption or clinical administration.
How fast does PX1 Research ship orders?
PX1 Research dispatches all orders placed before 1:00 PM EST Monday through Friday on the same business day. Shipments originate from our California and Arizona logistics facilities via expedited, fully tracked domestic carriers.
Do you provide a COA for my specific lot of MOTS-c or NAD+?
Yes. Every batch of MOTS-c and NAD+ sold by PX1 Research includes a lot-specific Certificate of Analysis detailing third-party HPLC, Mass Spectrometry, and endotoxin assay testing. COAs are accessible directly on product pages and included with orders.
What purity levels are guaranteed for PX1 Research peptides?
PX1 Research guarantees a minimum purity of 99.0% for both MOTS-c and NAD+ research products, verified by independent high-performance liquid chromatography (HPLC) peak integration testing.
How should MOTS-c lyophilized powder be stored upon arrival?
Lyophilized MOTS-c powder should be stored in a dry, dark place at -20°C for long-term stability. Avoid exposing unsealed vials to atmospheric humidity before they reach room temperature.
Can NAD+ be dissolved in standard bacteriostatic water?
NAD+ is readily soluble in sterile laboratory water or aqueous buffers. However, because it hydrolyzes rapidly in solution, reconstituted NAD+ should be used immediately or rapidly aliquoted and stored at -80°C.
What vial sizes are available for MOTS-c and NAD+?
MOTS-c is available in standard 10 mg lyophilized research vials. NAD+ is supplied in 100 mg and 500 mg research vials to support high-throughput in vitro and enzymatic assay requirements.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.